Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cluster-randomized Non-inferiority Trial Comparing Mupirocin vs Iodophor for Nasal Decolonization of ICU Patients to Assess Impact on S. Aureus Clinical Cultures and All-cause Bloodstream Infection During Routine Chlorhexidine Bathing

NCT03140423 is registered in ClinicalTrials.gov with Harvard Pilgrim Health Care as lead sponsor.

NCT NCT03140423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03140423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cluster-randomized Non-inferiority Trial Comparing Mupirocin vs Iodophor for Nasal Decolonization of ICU Patients to Assess Impact on S. Aureus Clinical Cultures and All-cause Bloodstream Infection During Routine Chlorhexidine Bathing
Lead sponsor
Harvard Pilgrim Health Care
Phase
Phase 4
Overall status
Completed
Start date
May 1, 2017
Completion date
November 6, 2023
Enrollment
353,323 (actual)
Sites
137

Conditions

As the registry lists them; a condition with its own page is linked.

staphylococcus aureus